\u00a0<\/p>\n
CVS Health Corp (NYSE:CVS)<\/a>\u00a0beat third-quarter earnings estimates, raised its 2026 financial forecasts and announced plans to split into two independent, publicly traded companies.<\/p>\n Adjusted earnings reached $2.09 a share, exceeding Wall Street’s $1.65 consensus estimate and rising from $1.60 a year earlier.<\/p>\n Revenue also beat expectations, increasing 5.4% to $108.4 billion for the quarter ended Sept. 30, against analysts’ forecast of $104.75 billion.<\/p>\n CVS raised its full-year adjusted earnings forecast to at least $8.20 a share from $7.90 to $8.10.<\/p>\n Its forecast under generally accepted accounting principles is now at least $6.98 a share, compared with the previous range of $6.84 to $7.04.<\/p>\n The operating cash flow forecast increased to at least $15.5 billion from at least $11.5 billion, after CVS<\/a> generated $15.3 billion through September.<\/p>\n CVS attributed the higher outlook to improvements in its insurance and pharmacy businesses, while remaining cautious about rising costs and potential economic headwinds.<\/p>\n Insurance adjusted operating income climbed to $912 million from $314 million a year earlier, primarily reflecting stronger performance in its government business.<\/p>\n Medical costs fell to 91.3% of premium revenue from 92.8%, while favorable revisions to prior years’ health care costs payable estimates totaled $1.3 billion during the first nine months.<\/p>\n